833 related articles for article (PubMed ID: 15533363)
1. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate.
Dudley PS; Heard MJ; Sangi-Haghpeykar H; Carson SA; Buster JE
Fertil Steril; 2004 Nov; 82(5):1374-8. PubMed ID: 15533363
[TBL] [Abstract][Full Text] [Related]
2. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
Hutchinson AP; Pereira N; Chung ER; Shah NJ; Zeku M; Chung PH; Rosenwaks Z
Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
[TBL] [Abstract][Full Text] [Related]
4. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
5. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy.
Natale A; Candiani M; Barbieri M; Calia C; Odorizzi MP; Busacca M
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):87-92. PubMed ID: 15474251
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate treatment for tubal pregnancy. Criteria for medical approach.
Cobellis G; Pierno G; Pecori E; Scaffa C; Stradella L; Messalli EM; Festa B; Cobellis L
Minerva Ginecol; 2003 Dec; 55(6):531-5. PubMed ID: 14676743
[TBL] [Abstract][Full Text] [Related]
7. Management of ectopic pregnancies with poor prognosis through ultrasound guided intrasacular injection of methotrexate, series of 14 cases.
Andrés MP; Campillos JM; Lapresta M; Lahoz I; Crespo R; Tobajas J
Arch Gynecol Obstet; 2012 Feb; 285(2):529-33. PubMed ID: 21837423
[TBL] [Abstract][Full Text] [Related]
8. Reproductive outcome after methotrexate treatment of tubal pregnancies.
Gervaise A; Masson L; de Tayrac R; Frydman R; Fernandez H
Fertil Steril; 2004 Aug; 82(2):304-8. PubMed ID: 15302275
[TBL] [Abstract][Full Text] [Related]
9. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
10. Time length of negativization of hCG serum values after either surgical or medical treatment of ectopic pregnancy.
Colacurci N; De Franciscis P; Zarcone R; Fortunato N; Passaro M; Mollo A; Russo G
Panminerva Med; 1998 Sep; 40(3):223-5. PubMed ID: 9785922
[TBL] [Abstract][Full Text] [Related]
11. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
12. Reproductive potential after methotrexate treatment of ectopic gestation in a community hospital.
Tolaymat LL; Brown TL; Maher JE; Horan CA; Green BA; Ripps BA
J Reprod Med; 1999 Apr; 44(4):335-8. PubMed ID: 10319302
[TBL] [Abstract][Full Text] [Related]
13. What is the significance of the human chorionic gonadotropin value in ectopic pregnancy?
DiMarchi JM; Kosasa TS; Hale RW
Obstet Gynecol; 1989 Dec; 74(6):851-5. PubMed ID: 2586949
[TBL] [Abstract][Full Text] [Related]
14. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies.
Nazac A; Gervaise A; Bouyer J; de Tayrac R; Capella-Allouc S; Fernandez H
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):181-5. PubMed ID: 12601843
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of single-dose and multiple-dose methotrexate therapy on tubal patency.
Guven ES; Dilbaz S; Dilbaz B; Ozdemir DS; Akdag D; Haberal A
Fertil Steril; 2007 Nov; 88(5):1288-92. PubMed ID: 17418839
[TBL] [Abstract][Full Text] [Related]
16. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?
Nguyen Q; Kapitz M; Downes K; Silva C
Am J Obstet Gynecol; 2010 Jun; 202(6):630.e1-5. PubMed ID: 20510964
[TBL] [Abstract][Full Text] [Related]
17. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
18. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy.
Lipscomb GH; Givens VA; Meyer NL; Bran D
Fertil Steril; 2004 May; 81(5):1221-4. PubMed ID: 15136080
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.
Soliman KB; Saleh NM; Omran AA
Saudi Med J; 2006 Jul; 27(7):1005-10. PubMed ID: 16830020
[TBL] [Abstract][Full Text] [Related]
20. Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling.
Cohen A; Bar-On S; Cohen Y; Sandel O; Fouks Y; Michaan N; Tzur T; Levin I
Reprod Sci; 2022 Apr; 29(4):1209-1214. PubMed ID: 35157263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
